Carisma Therapeutics (CARM) Q3 2024 Earnings

8AugConfirmed
Q2 2024
Q3 2024
-0.46
-0.4
-0.33
-0.27

Details

Expected EPS
-0.296
Actual EPS
-0.27
Surprise EPS
0.03
Surprise Percent
+8.78%

Description

Carisma Therapeutics (CARM) has reported earnings of -0.27 per share for Q3 2024.

0 Comments

Share your thoughts